News Lilly axes trial of Hanmi's arthritis drug Lilly may decide to develop drug in other indications
Digital South Korea hopes big data will boost life sciences industry South Korea is to build a comprehensive database of genetic and biometric data from 10 million people, in a bid to boost its pharma and biotech industry.
Views & Analysis Digital Health Round-up – NHS & DeepMind, funding for Apreci... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
